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Thispaperpresentsarareconditionasadifferential
diagnosis in a teenager with right iliac fossa pain.
Case report
A 16-year-old male patient who was previously ﬁt
and healthy presented initially with sudden onset
of lower abdominal pain. He had not suffered
from similar pain in the past. He had not suffered
from any signiﬁcant medical diseases. He smoked
up to 16 cigarettes a day, his bowel and bladder
habits were regular. There was no family history
of inﬂammatory bowel disease. Physical examin-
ation revealed his heart rate was 111 beats per
minute and he was apyrexial. On abdominal
examination he was tender over both iliac fossae,
more on the right side. Blood tests showed white
cell count was 12 and C-reactive protein was <6.
Urinalysis was positive for nitrates and protein.
Based on his clinical presentation and elevated
white cell count he was diagnosed to have appen-
dicitis. He went on to have open appendectomy;
later we found the histology did not reveal any
inﬂammation.
Threemonthslatertheteenagerpresentedagain
with right iliac fossa pain and signs of local perito-
nitis.Laboratorytestsrevealedwhitecellcountwas
18.1 and C-reactive protein was 51. A laparoscopy
was performed which showed postoperative adhe-
sions which were released. This was followed by
recovery and discharge from the hospital. Follow-
ing his discharge he re-presented within a period
of two months with right iliac fossa pain and an
elevated white cell count of 13 and C-reactive
protein of 248. The clinical presentation was inves-
tigated with a computed tomography (CT) scan of
the abdomen and pelvis which did not reveal any
abnormality in the right iliac fossa; the rest of the
abdomen was unremarkable.
Persisting pain and escalating inﬂammatory
markers prompted a laparotomy which revealed
thickened ileocaecal area suggestive of inﬂamma-
tory bowel disease. Following recovery, the provi-
sional diagnosis of inﬂammatory bowel disease
was investigated with colonoscopy with terminal
ileal biopsies, oesophagogastroduodenoscopy
and barium-follow-through all of which were in
the normal range. However the barium follow-
through, all of which were normal. An isotope-
scan (white cell tagged) showed inﬂammation of
the distal small bowel. Following a gastroenterol-
ogy consultation, the patient was commenced on
systemic steroids for suspected Crohn’s disease.
Ten days later, a further admission (ﬁfth) with
similar symptoms and signs warranted a CTscan,
which demonstrated multiple mildly dilated
ﬂuid ﬁlled loops of small bowel with no other sig-
niﬁcant pathology. He underwent a subsequent
diagnostic laparoscopy where further division
of adhesions was performed. There was evidence
of scarring in the terminal ileum (Figure 1) and a
full thickness biopsy of the abnormal ileum was
taken. The biopsy revealed evidence of serositis
without any histological features of Crohn’s
disease.
Compounding the diagnostic conundrum, the
teenage patient was admitted for the sixth
episode with a similar presentation. Prompted by
recurrent admissions, impairment of the patient’s
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1quality of life and after extensive discussion with
the patient it was decided to proceed to diagnostic
laparoscopy and limited right hemicolectomy as
the visible disease process was conﬁned to that
region. The surgery was undertaken on an urgent
basis. Recovery was uneventful and cessation of
symptoms was observed at the 10-month
follow-up. Histology of the resected specimen
revealed sclerosing mesenteritis (Figure 2), which
is relatively rare pathology in a teenage patient.
Discussion
Sclerosing mesenteritis is a rare, benign inﬂamma-
tory disorder of unknown aetiology, affecting the
membranes of the digestive tract. The commonest
site affected is the mesentery of the small bowel
and more rarely the disease affects the mesoco-
lon,
1 peripancreatic region, omentum and pelvis.
Characteristic features include fat necrosis, ﬁbrosis
and chronic inﬂammation. Sclerosing mesenteritis
usually presents in the ﬁfth and sixth decades and
is twice as common in men than in women.
2 Scler-
osing mesenteritis is synonymous with mesenteric
lypodystrophy, retractile mesenteritis, mesenteric
panniculitis and mesenteric sclerosis.
The aetiology of sclerosing mesenteritis is idio-
pathic in most cases but the disease is known to
have association with previous abdominal
surgery; retroperitoneal ﬁbrosis, Riedel’s thyroid-
itis, sclerosing cholangitis, vasculitis and granulo-
matous disorders. Clinical features are variable;
abdominal pain is the most common symptom
but sclerosing mesenteritis also presents with dis-
tension/bloating, diarrhoea, weight loss, fever,
abdominal mass and bowel obstruction. Clinical
examination does not contribute much to the diag-
nosis of sclerosing mesenteritis apart from non-
localizing tenderness and the presence of an
abdominal mass in rare cases.
Diagnosis of sclerosing mesenteritis is radio-
logical, histopathological or incidental. CT scan
ﬁndings may include the appearance of a hetero-
geneous soft tissue mass in the mesentery of the
small bowel, entrapment of the superior mesen-
teric artery with no vascular involvement, and
no invasion of adjacent small bowel loops. Two
CT ﬁndings are considered more speciﬁc for the
diagnosis of sclerosing mesenteritis
3:
• The presence of a tumour pseudo-capsule,
which is a hyperattenuated stripe surrounding
the mass in the mesentery of the small bowel.
This is seen in 60% of cases;
• The ‘fat ring’ sign of hypodense fatty halo sur-
rounding mesenteric nodules and vessels.
This is seen in up to 75% of cases;
• The deﬁnitive diagnosis of sclerosing mesenter-
itis is made through histological analysis of
specimens obtained laparoscopically or
through open laparotomy.
Figure 1
White patchy lesion at ileocaecal junction on a
background of scarring and abnormal vasculature
seen during laparoscopy 133× 91 mm (300× 300
DPI)
Figure 2
Histopathology specimen from right hemicolect-
omy showing chronic inﬂammation of the
mesentery with ﬁbrosis 149× 121 mm (150× 150
DPI)
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Daniel MarksIn the early stage when fat necrosis predominates
with little or no ﬁbrosis, the diagnosis of mesenteric
lipodystrophy has been used. Later, when fat necro-
sis subsides and chronic inﬂammation becomes
predominant, it may be designated mesenteric
panniculitis. Finally, when ﬁbrosis becomes the
main feature, sclerosing or retractile mesenteritis
has been used.
2 On immunohistochemical staining,
sclerosing mesenteritis specimens stain positive for
vimentin, desmin and b-cathepsin suggesting
increased myoﬁbriblastic activity
4 and negative for
desmin, keratin, and S-100 protein.
5
Treatment is tailored to the patient’s individual
symptoms, accompanying conditions and compli-
cations. In one study conducted by Akram et al. of
ninety two patients, 52% of patients did not receive
any treatment, 26% were treated with medical
therapy alone, 13% with surgery alone and 9%
with both surgical and medical therapy.
6 Corticos-
teroids,colchicine,azathioprine,thalidomide,cyclo-
phosphamide, tamoxifen, progesterone are some of
thetherapeuticagentsusedwithvariedresults.Our
patient was commenced on steroids and the litera-
ture does suggest better efﬁcacy with combination
treatment which mayexplain that lackof resolution.
Surgical treatment options may range from excision
of the mass to resection of small/large bowel.
Differential diagnoses of sclerosing mesenteritis
are inﬂammatory bowel disease, extra-abdominal
fat necrosis (Weber-Christian disease), pancreatitis,
retroperitoneal ﬁbrosis, desmoids, carcinomatosis,
carcinoid, primary mesenteric mesothelioma and
B-cell lymphoma.
7 Sclerosing mesenteritis is a
benigndiseasebutleftuntreatedrunsaratherdebil-
itating course. Complications include bowel
obstruction, gastrointestinal bleeding and arterial/
venous thrombosis. Fatal outcomes have been
reported due to these complications.
In summary there is no agreed management of
sclerosing mesenteritis, however literature
suggests watchful waiting could be done in cases
with fat necrosis alone,
1 once chronic inﬂam-
mation sets in various immunosuppressive thera-
pies are suggested
6,8,9 and surgery is reserved for
failed medical therapy and complications.
10
Conclusion
Sclerosing mesenteritis is a rare non-neoplastic
idiopathic inﬂammatory disorder commonly affect-
ing adults who are middle-aged or older. The take
home message from our report is that this condition
can be seen in a young adult which was initially
mimicking appendicitis, and later inﬂammatory
bowel disease. However, the diagnostic conundrum
w a sr e s o l v e db ys u r g e r ya n dt h eh i s t o l o g yo ft h e
specimen.
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